Closure Medical Corporation  
Closure Medical Corporation
News   Contact Us   Site Map   Home  
 
About Us
Our Products
Medical Professionals
Consumers
Prospective Employees
Client Login
 

News Releases

June 2, 2005
Closure Medical Stockholders Approve Acquisition Agreement With Johnson & Johnson

March 4, 2005
Johnson & Johnson and CLOSURE Medical Corporation Announce Acquisition Agreement
Acquisition to Strengthen Presence in Topical Adhesives and Surgical Sealants

February 23, 2005
Closure Medical Reports Fourth Quarter and Fiscal Year 2004 Results

February 22, 2005
Closure Medical Receives European Approval For OMNEX™ Surgical Sealant, Its First Internal Product

February 18, 2005
Closure Medical Announces Date of Its Fourth Quarter and Year-End 2004 Results Release and Conference Call

February 03, 2005
Closure Medical Corporation To Present At The Merrill Lynch 2005 Global Pharmaceutical, Biotechnology & Medical Device Conference

January 11, 2005
Closure Medical Provides 2005 Financial Guidance

January 6, 2005
Closure Medical Corporation To Present At The Seventh Annual Needham Growth Conference

December 16, 2004
Closure Medical Announces Date Of Its 2005 Financial Guidance Release And Conference Call

October 13, 2004
Closure Medical Reports Third Quarter 2004 Results

October 6, 2004
Closure Medical Announces Date of Its Third Quarter 2004 Results Release and Conference Call

September 29, 2004
Closure Medical Revises 2004 Financial Outlook

July 22, 2004
Closure Medical Reports 33 Percent Increase In Revenues And 52 Percent Increase In Net Income For Second Quarter 2004

July 15, 2004
Closure Medical Announces Date Of Its Second Quarter 2004 Results Release And Conference Call

June 16, 2004
Closure Medical Elects J. Daniel Cole Chairman Of The Board Of Directors

June 1, 2004
Closure Medical Corporation To Present At The Pacific Growth Equities Life Sciences Growth Conference

April 15, 2004
Closure Medical Reports First Quarter Revenues of $10.5 Million, Up 28 Percent From Prior Year Period

April 13, 2004
Closure Medical Receives Medical Design Excellence Award

March 18, 2004
Closure Medical announces FDA approval to begin pivotal clinical study for its vascular sealant product

February 12, 2004
Closure Medical reports fourth quarter 2003 results

January 6, 2004
Closure Medical appoints three new Vice Presidents

November 20, 2003
Closure Medical provides 2004 financial guidance

November 4, 2003
Closure Medical Corporation initiates patient enrollment in pilot study for its vascular sealant product

October 20, 2003
Closure Medical Introduces new Dermabond delivery devices

October 16, 2003
Closure Medical reports third quarter 2003 results

October 2, 2003
Stephen I. Shapiro joins board of Closure Medical Corporation

September 17, 2003
Closure Medical to present at the UBS Warburg Global Life Sciences conference

July 17, 2003
Closure Medical reports record second quarter results

July 1, 2003
J. Daniel Cole joins board of Closure Medical Corporation

April 16, 2003
Closure Medical reports first quarter results

March 17, 2003
Closure Medical names James F. Buck Vice President of Marketing

February 14, 2003
Closure Medical reports record earnings and double-digit revenue growth for its fourth quarter and full year 2002

January 29, 2003
Closure Medical Corp to present at Merrill Lynch Global Pharmaceutical, Biotech & Medical Device conference in New York City

January 22, 2003
Band Aid Brand® Liquid Bandage receives Good Housekeeping's "Good Buy" award

January 2, 2003
Closure Medical receives FDA approval to market its new high viscosity Dermabond topical skin adhesive

October 17, 2002
Closure Medical reports third quarter, nine month results

September 4, 2002
Daniel A. Pelak appointed as President and Chief Executive Officer of Closure Medical

July 23, 2002
Closure Medical reports second quarter 2002 results

April 23, 2002
Closure Medical reports first quarter 2002 results

February 19, 2002
Closure Medical reports fourth quarter and year-end 2001 results

January 24, 2002
Closure Medical Corporation to participate in the U.S. Bancorp Piper Jaffray Health Care conference

January 16 , 2002
Dermabond adhesive receives FDA approval for enhanced device labeling

November 26 , 2001
Closure Medical Corporation to participate in the Robertson Stephens medical conference

November 7 , 2001
Closure Medical provides Johnson & Johnson Wound Management exclusive rights to occlusive dressing technology, the company's fifth major product platform

October 23 , 2001
Closure Medical Corporation reports record revenue and earnings for the third quarter and first nine months of 2001; expects 30-35% revenue growth for 2002

October 16 , 2001
James E. Niedel, former Chief Science and Technology Officer of GlaxoSmithKline PLC, joins board of Closure Medical Corporation

October 16 , 2001
Closure Medical to webcast conference call discussing third quarter 2001 results and outlook for 2002

July 30, 2001
Closure Medical adopts stockholder rights plan

July 24, 2001
Closure Medical Corporation reports record revenues for the second quarter and first half of 2001

July 17, 2001
Closure Medical announces agreement with Abbott Laboratories for Nexaband® product line for veterinary wound care

May 29, 2001
Closure Medical signs definitive agreement with Johnson & Johnson Consumer Companies, Inc. for its Liquiderm™ liquid adhesive bandage

April 24, 2001
Closure Medical reports first quarter results

April 17, 2001
Closure Medical to webcast first quarter 2001 conference call

February 20, 2001
Closure Medical reports fourth quarter results

February 6, 2001
Closure enters research agreement to develop medical adhesive for the treatment of emphysema

January 31, 2001
Closure Medical Corporation announces FDA approval of Liquiderm™ Liquid Adhesive Bandage

January 11, 2001
Closure Medical provides guidance for Q4 2000 and for fiscal year 2001

December 21, 2000
Closure Medical announces Soothe-n-Seal™ agreement with Colgate

October 26, 2000
Closure Medical reports third quarter results

October 23, 2000
Closure Medical schedules date for third-quarter financial results and conference call

August 1, 2000
Closure Medical files 510(k) application for U.S. marketing clearance of its Liquiderm™ Liquid Adhesive Bandage

July 25, 2000
Closure Medical reports second quarter results

April 25, 2000
Closure Medical reports first quarter results

March 28, 2000
Closure Medical announces human clinical study for Liquiderm™ Liquid Healing Bandage

February 16, 2000
Closure Medical Corporation receives clearance for marketing Dermabond® in Japan

February 16, 2000
Closure Medical Corporation reports fourth quarter results

December 8, 1999
Closure Medical Corporation elects Ronald A. Ahrens as chairman of its board of directors

October 21, 1999
Closure Medical Corporation reports third quarter results

September 7, 1999
Closure Medical announces FDA approval of Soothe-n-Seal™ canker sore relief

August 4, 1999
Closure Medical Corporation awarded U.S. patent relevant to Dermabond™ topical skin adhesive

July 15, 1999
Closure Medical Corporation reports second quarter results

June 8, 1999
Closure Medical Corporation announces filing of 510(k) for Soothe-n-Seal™ canker sore relief

April 22, 1999
Closure Medical Corporation reports first quarter results

February 19, 1999
TV drama “ER” showcases new Dermabond™ topical skin adhesive

February 10, 1999
Closure Medical Corporation reports fourth quarter results

January 4, 1999
Ronald A. Ahrens joins Closure Medical Corporation board of directors

November 23, 1998
One-year follow-up highlights excellent cosmetic results with Dermabond™ topical skin adhesive

October 21, 1998
Closure Medical Corporation third quarter results

August 27, 1998
Closure Medical announces FDA approval of Dermabond™ topical skin adhesive

July 27, 1998
Closure Medical Corporation announces second quarter results

June 3, 1998
Closure Medical completes pilot clinical study for treatment of oral ulcers

April 20, 1998
Closure Medical Corporation announces first quarter results

March 31, 1998
Debra L. Pawl joins Closure Medical Corporation as Vice President and General Counsel

March 11, 1998
Closure Medical relocates to 50,000 square foot facility

February 2, 1998
Closure Medical Corporation fourth quarter results

January 30, 1998
FDA advisory panel recommends approval of Closure Medical Corporation's Dermabond™ topical skin cohesive

 

Real People. Real Healing.